These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21921794)

  • 41. [Sleep apnea--effect of CPAP--therapy of difficult to control arterial hypertension].
    Storre JH
    Pneumologie; 2008 Mar; 62(3):120. PubMed ID: 18370352
    [No Abstract]   [Full Text] [Related]  

  • 42. Obstructive sleep apnoea and stroke.
    Hui DS
    Respirology; 2006 Nov; 11(6):678-80. PubMed ID: 17052293
    [No Abstract]   [Full Text] [Related]  

  • 43. Early CPAP use identifies subsequent adherence to CPAP therapy.
    Budhiraja R; Parthasarathy S; Drake CL; Roth T; Sharief I; Budhiraja P; Saunders V; Hudgel DW
    Sleep; 2007 Mar; 30(3):320-4. PubMed ID: 17425228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compliance, education, monitoring in the treatment of obstructive sleep apnea by nasal continuous positive airway pressure.
    Delguste P; Rodenstein DO
    Sleep; 2000 Jun; 23 Suppl 4():S158-60. PubMed ID: 10893093
    [No Abstract]   [Full Text] [Related]  

  • 45. Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study.
    Trenaman L; Sadatsafavi M; Almeida F; Ayas N; Lynd L; Marra C; Stacey D; Bansback N
    Med Decis Making; 2015 Jul; 35(5):671-82. PubMed ID: 25344130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An in-patient model for positive airway pressure desensitization: a report of 2 pediatric cases.
    Harford KL; Jambhekar S; Com G; Bylander L; Pruss K; Teagle J; Ward W
    Respir Care; 2012 May; 57(5):802-7. PubMed ID: 22152821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Social factors associated with CPAP acceptance.
    Aloia MS
    Sleep; 2009 Apr; 32(4):443-4. PubMed ID: 19413139
    [No Abstract]   [Full Text] [Related]  

  • 48. Service redesign. The big sleep problem.
    Moore A
    Health Serv J; 2013 Nov; 123(6376):Suppl 2-3. PubMed ID: 24416969
    [No Abstract]   [Full Text] [Related]  

  • 49. Why CMS approved home sleep testing for CPAP coverage.
    Chediak AD
    J Clin Sleep Med; 2008 Feb; 4(1):16-8. PubMed ID: 18350957
    [No Abstract]   [Full Text] [Related]  

  • 50. [Trends in prevalence of continuous positive airway pressure treatment for adults from 2006 to 2010].
    Ha-Vinh P; Randelli P; Régnard P
    Rev Mal Respir; 2013 Jan; 30(1):44-55. PubMed ID: 23318189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of CPAP treatment related to cardiovascular disease in patients with severe OSAS: the Greek experience.
    Mermigkis C; Bouloukaki I; Schiza SE
    Sleep Breath; 2015 May; 19(2):737-9. PubMed ID: 25304123
    [No Abstract]   [Full Text] [Related]  

  • 52. Weaving the Internet of Sleep: The Future of Patient-Centric Collaborative Sleep Health Management Using Web-Based Platforms.
    Stepnowsky C; Sarmiento KF; Amdur A
    Sleep; 2015 Aug; 38(8):1157-8. PubMed ID: 26194574
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment adherence should be taken into account when reporting treatment outcomes in obstructive sleep apnea.
    Ravesloot MJ; de Vries N; Stuck BA
    Laryngoscope; 2014 Jan; 124(1):344-5. PubMed ID: 23832815
    [No Abstract]   [Full Text] [Related]  

  • 54. Achieving adherence to positive airway pressure therapy: modifying pressure and the Holy Grail.
    Brown LK
    Chest; 2011 Jun; 139(6):1266-1268. PubMed ID: 21652553
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to comment on Guest et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 2014;37:1263-1271.
    Taheri S; Guest JF; Stradling JR
    Diabetes Care; 2014 Sep; 37(9):e202-3. PubMed ID: 25147264
    [No Abstract]   [Full Text] [Related]  

  • 56. Behavioral economics strategies for promoting adherence to sleep interventions.
    Stevens J
    Sleep Med Rev; 2015 Oct; 23():20-7. PubMed ID: 25645127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The economic impact of obstructive sleep apnea.
    AlGhanim N; Comondore VR; Fleetham J; Marra CA; Ayas NT
    Lung; 2008; 186(1):7-12. PubMed ID: 18066623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Probabilistic cost-effectiveness analysis of the treatment of sleep apnea].
    Mar J; Gutiérrez-Moreno S; Chilcott J
    Gac Sanit; 2006; 20(1):47-53. PubMed ID: 16539993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The new local coverage determination criteria for adherence to positive airway pressure treatment: testing the limits?
    Aloia MS; Knoepke CE; Lee-Chiong T
    Chest; 2010 Oct; 138(4):875-9. PubMed ID: 20348198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comment on Guest et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 2014;37:1263-1271.
    Tahrani AA
    Diabetes Care; 2014 Sep; 37(9):e200-1. PubMed ID: 25147263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.